Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Supprelin LA
(United States) [Available]Synonyms :
histrelin 
Class :
Antineoplastics and GnRH Antagonist
Brand Name :
Supprelin LA
(United States) [Available]Synonyms :
histrelin 
Class :
Antineoplastics and GnRH Antagonist
Dosage Forms & Strengths Â
Implant Â
50mg Â
50mcg/day   Â
50 mg implant given SC for every 12 months
The maximum duration of treatment includes removing the implant after 12 months
Dose Adjustments
Renal Impairment:
Dose adjustment not required
Liver impairment:
No data available
Dosage Forms & Strengths Â
Implant Â
50mg Â
65mcg/day   Â
age: >2 years
50 mg implant given SC for every 12 months
The maximum duration of treatment includes removing the implant after 12 months
when both drugs are combined, there may be increased toxicity of nilotinib by qtc interval  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
QTc interval is increased both by lenvatinib and histrelin
Progestins may reduce the therapeutic efficacy
when both drugs are combined, there may be a reduced therapeutic efficacy of albiglutide  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
Adverse drug reactions Â
Frequency defined Â
>10% Â
Hot flashes  Â
1-10% Â
Anemia Â
Constipation Â
Decreased libido Â
Erectile dysfunction Â
Fatigue Â
Headache Â
Insomnia Â
Weight gain Â
Gynecomastia Â
Testicular atrophy Â
Hepatic disorder Â
Implant site reaction Â
Â
Pregnancy warnings:   Â
Breastfeeding warnings:Â
Pregnancy Categories:     Â
Patient Information Leaflet Â
Generic Name: histrelin (Rx)  Â
Pronounced: hiss -tre-linÂ
 Â
Why do we use histrelin?Â
histrelin is an anticancer drug, and GnRH agonist used to treat central precocious puberty and advanced prostate cancer.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
